Patents by Inventor Gloria TEN FIGAS

Gloria TEN FIGAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10351515
    Abstract: The present invention concerns new forms of crystalline minocycline base. In particular, two new crystalline polymorphic forms, designated Form IV and Form V of minocycline base are provided. These are characterized by XRD, FTIR and TGA. Processes for preparing the new polymorphic forms and their use in pharmaceutical compositions are also provided. Form IV and form V are prepared by dissolving and/or suspending minocycline base in an organic solvent followed by crystallization.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: July 16, 2019
    Assignee: Hovione Scientia Limited
    Inventors: Zita Mendes, Constanca Cacela, Gloria Ten Figas, Ana Fernandez Casares
  • Patent number: 10351516
    Abstract: Described are new forms of crystalline minocycline base. In particular, two new crystalline polymorphic forms, designated Form IV and Form V of minocycline base are provided. These are characterized by XRD, FTIR and TGA. Processes for preparing the new polymorphic forms and their use in pharmaceutical compositions are also provided. Form IV and Form V are prepared by dissolving and/or suspending minocycline base in an organic solvent followed by crystallization.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: July 16, 2019
    Assignee: Hovione Scientia Limited
    Inventors: Zita Mendes, Constanca Cacela, Gloria Ten Figas, Ana Fernandez Casares
  • Patent number: 10280173
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: May 7, 2019
    Assignee: WAVELENGTH ENTERPRISES LTD
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernandez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • Publication number: 20180339962
    Abstract: Described are new forms of crystalline minocycline base. In particular, two new crystalline polymorphic forms, designated Form IV and Form V of minocycline base are provided. These are characterized by XRD, FTIR and TGA. Processes for preparing the new polymorphic forms and their use in pharmaceutical compositions are also provided. Form IV and Form V are prepared by dissolving and/or suspending minocycline base in an organic solvent followed by crystallization.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 29, 2018
    Applicant: Hovione Scientia Limited
    Inventors: Zita Mendes, Constanca Cacela, Gloria Ten Figas, Ana Fernandez Casares
  • Publication number: 20180251463
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Application
    Filed: December 22, 2017
    Publication date: September 6, 2018
    Applicant: WAVELENGTH ENTERPRISES LTD.
    Inventors: Itai ADIN, Sonia KRIVONOS, Yevgeny ROZENBLAT, Alex WEISMAN, Ana FERNANDEZ CASARES, Gloria TEN FIGAS, Revital BEN-DANIEL
  • Patent number: 9884869
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Grant
    Filed: March 23, 2015
    Date of Patent: February 6, 2018
    Assignee: PERRIGO API LTD.
    Inventors: Itai Adin, Sonia Krivonos, Yevgeny Rozenblat, Alex Weisman, Ana Fernadez Casares, Gloria Ten Figas, Revital Ben-Daniel
  • Publication number: 20180029977
    Abstract: The present invention concerns new forms of crystalline minocycline base. In particular, two new crystalline polymorphic forms, designated Form IV and Form V of minocycline base are provided. These are characterized by XRD, FTIR and TGA. Processes for preparing the new polymorphic forms and their use in pharmaceutical compositions are also provided. Form IV and form V are prepared by dissolving and/or suspending minocycline base in an organic solvent followed by crystallization.
    Type: Application
    Filed: February 12, 2016
    Publication date: February 1, 2018
    Applicant: Hovione Scientia Limited
    Inventors: Zita Mendes, Constanca Cacela, Gloria Ten Figas, Ana Fernandez Casares
  • Publication number: 20170226108
    Abstract: Provided are ibrutinib polymorphs, e.g., crystalline ibrutinib Forms III, IV, V, VI, VII, VIII and Form IX and processes for producing these crystalline forms, stable amorphous ibrutinib and processes for preparing stable amorphous ibrutinib, pharmaceutical compositions comprising these forms and methods of using these crystalline and amorphous forms.
    Type: Application
    Filed: March 23, 2015
    Publication date: August 10, 2017
    Applicant: PERRIGO API LTD.
    Inventors: Itai ADIN, Sonia KERIVONOS, Yevgeny ROZENBLAT, Alex WEISMAN, Ana FERNADEZ CASARES, Gloria TEN FIGAS, Revital BEN-DANIEL